MARCHINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 12.079
EU - Europa 6.919
AS - Asia 4.570
SA - Sud America 481
AF - Africa 172
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 13
AN - Antartide 1
Totale 24.263
Nazione #
US - Stati Uniti d'America 11.640
CN - Cina 1.824
IT - Italia 1.442
SG - Singapore 1.367
RU - Federazione Russa 1.353
PL - Polonia 1.307
DE - Germania 788
GB - Regno Unito 427
BR - Brasile 391
FR - Francia 371
CA - Canada 362
VN - Vietnam 361
HK - Hong Kong 348
UA - Ucraina 339
SE - Svezia 310
FI - Finlandia 240
TR - Turchia 143
KR - Corea 134
ZA - Sudafrica 123
IN - India 102
IE - Irlanda 79
MX - Messico 48
NL - Olanda 47
BD - Bangladesh 43
JP - Giappone 39
AR - Argentina 37
BE - Belgio 36
AT - Austria 35
ES - Italia 33
CZ - Repubblica Ceca 27
EU - Europa 26
PK - Pakistan 26
IR - Iran 22
EG - Egitto 16
RO - Romania 16
BH - Bahrain 15
IQ - Iraq 15
EC - Ecuador 14
LT - Lituania 14
AE - Emirati Arabi Uniti 12
MY - Malesia 12
UZ - Uzbekistan 12
TW - Taiwan 11
VE - Venezuela 11
ID - Indonesia 10
AU - Australia 9
KE - Kenya 9
CL - Cile 8
HN - Honduras 8
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
PH - Filippine 7
PT - Portogallo 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
CO - Colombia 6
MA - Marocco 6
RS - Serbia 6
CH - Svizzera 5
JM - Giamaica 5
KG - Kirghizistan 5
NP - Nepal 5
PY - Paraguay 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
LV - Lettonia 4
PE - Perù 4
SI - Slovenia 4
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
EE - Estonia 3
HU - Ungheria 3
MD - Moldavia 3
ML - Mali 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
SY - Repubblica araba siriana 3
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
Totale 24.244
Città #
Warsaw 1.152
Ashburn 1.010
Fairfield 992
Woodbridge 961
Jacksonville 812
Singapore 683
Houston 664
San Jose 638
Chandler 601
Ann Arbor 508
Wilmington 473
Seattle 464
Cambridge 356
Hong Kong 339
Boardman 332
Camerino 298
Nanjing 278
Beijing 253
Toronto 206
The Dalles 194
Los Angeles 185
New York 169
Dallas 156
Council Bluffs 153
Kraków 146
Dearborn 130
Seoul 128
San Mateo 126
Tongling 122
Helsinki 117
Johannesburg 113
Lauterbourg 112
Princeton 107
Lawrence 106
Columbus 100
Istanbul 100
Ho Chi Minh City 98
Nanchang 98
London 96
Ogden 92
Düsseldorf 83
Dublin 79
Moscow 77
Hanoi 75
Buffalo 72
Lachine 72
Milan 66
Kunming 62
Shanghai 57
Shenyang 57
São Paulo 51
Dong Ket 50
Chicago 49
Santa Clara 49
San Diego 48
Centro 47
Tianjin 47
Guangzhou 46
Hebei 45
Munich 44
Orem 44
Jinan 42
Rome 42
Jiaxing 41
Montreal 41
Hefei 35
Tokyo 35
Brussels 34
St Louis 34
Denver 32
Verona 32
Brooklyn 31
Falls Church 31
Changsha 30
Hangzhou 30
Zhengzhou 30
Venezia 28
Vienna 27
Phoenix 26
Redwood City 26
Trieste 25
Valle 25
Chennai 24
Atlanta 23
Ningbo 23
Bologna 22
Da Nang 21
Athens 19
Brno 19
Philadelphia 19
Wuhan 19
Mumbai 18
Redondo Beach 18
Amsterdam 17
Napoli 17
San Francisco 17
Jinhua 16
Manchester 16
Nürnberg 16
Rio de Janeiro 16
Totale 15.905
Nome #
Antioxidant and antiproliferative activities of different varieties of cauliflower (Brassica oleracea var. botrytis) after cooking processes. 482
Complessi di rutenio con attività chemioterapica antitumorale 430
Personalized liposome–protein corona in the blood of breast, gastric and pancreatic cancer patients 402
In vivo protein corona patterns of lipid nanoparticles 391
The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery 365
VirF Relieves the Transcriptional Attenuation of the Virulence Gene icsA of Shigella flexneri Affecting the icsA mRNA-RnaG Complex Formation 338
The water soluble ruthenium(II) organometallic compound[Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Clsuppresses triple negative breast cancer growth by inhibiting tumorinfiltration of regulatory T cells 328
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition 326
Resveratrol fuels HER2 and ERα‐positive breast cancer behaving as proteasome inhibitor 324
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 321
Aspirin modulates LPS-induced nitric oxide release in rat glial cells 318
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 286
Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells 282
Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer 282
A novel 39-tRNAGlu-derived fragment acts as a tumor-suppressor in breast cancer by targeting nucleolin 273
Tailoring DNA vaccines: designing strategies against HER2-positive cancers 268
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 266
Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD) 263
Cholesterol dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO Living Cells 260
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. 260
HER2-Driven carcinogenesis: new mouse models for novel immunotherapies 257
Azolate/phosphane Gold(I) compounds in antiproliferative therapy: a new frontier for the azolate gold(I) chemistry 257
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 256
Tumor vessel compression hinders perfusion of ultrasonographic contrast agents 254
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer 254
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling 253
Combination of Coenzyme Q10 intake and moderate physical activity counteracts mitochondrial dysfunctions in a SAMP8 mouse model Oxidative Medicine and Cellular Longevity. 251
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2- positive breast carcinomas resistant to Lapatinib 250
NANOPARTICELLE LIPIDICHE MULTICOMPONENTI E PROCEDIMENTI PER LA LORO PREPARAZIONE 245
Azolate gold(I) phosphane complexes as innovative therapies for the treatment of HER2-driven breast cancer 242
Factors Determining the Superior Performance of Lipid/DNA/Protammine Nanoparticles over Lipoplexes. 237
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells 236
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 236
Cyclooxygenase-2 (COX2) gene silencing with siRNA could enhance DNA vaccination to inhibit established ErbB-2 carcinomas 234
Structure-function relationships in bovine thymus 20S proteasome: a fluorimetric study 233
Getting the most from gene delivery by repeated DNA transfections 233
IN VITRO AND IN VIVO STUDIES FOR THE TREATMENT OF BASAL LIKE BREAST CANCER (BLBC) WITH AZOLATE/PHOSPHANE GOLD(I) COMPOUNDS 232
Role of temperature-independent lipoplex-cell membrane interactions in the efficiency boost of multicomponent lipoplexes. 229
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 226
Characterization of an inwardly rectifying chloride conductance expressed by cultured rat cortical astrocytes. 222
Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition 221
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients 221
Tailoring lipoplex composition to the lipid composition of plasma membrane: a Trojan horse for cell entry? 219
Vaccination trials against bovine herpesvirus-1 216
Toward the Rational Design of Lipid Gene Vectors: Shape Coupling between Lipoplex and Anionic Cellular Lipids Controls the Phase Evolution of Lipoplexes and the Efficiency of DNA Release 214
Ruthenium Complexes with Antitumoral Chemiotherapy Activites 213
Antiproliferative Activity of a New (Arene)Ruthenium(II) Complex on a Model of Breast Cancer 209
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 207
Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells 207
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 205
Transfection efficiency boost by designer multicomponent lipoplexes 202
Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules 201
Transfection efficiency boost of cholesterol-containing lipoplexes 200
Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity 198
Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density 196
Costrutto di acido nucleico, vettore e vaccino a DNA includenti detto costrutto 195
LIBRERIA FAGICA DI FRAMMENTI DELLA PROTEINA HER2 193
Homeostatic effects of adenosine on potentially neurotoxic glial cell activation. 192
Novel Mechanisms of Cell Uptake in Lipid-Mediated Gene Delivery 192
Protective mechanisms of adenosine in neurons and glial cells. 192
On the correlation between phase evolution of lipoplexes/anionic lipid mixtures and DNA release 190
DNA release from cationic liposome/DNA complexes by anionic lipids 190
p185neu encoding DNA and therapeuticaluses thereof 189
P185neu-encoding DNA and therapeutical uses thereof 187
Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes 187
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 186
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 185
Surface adsorption of protein corona controls the cell uptake mechanism in efficient cationic liposome/DNA complexes in serum. 184
Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination 183
The Second Ascoli Piceno Conference on Gene Vacciantion in Cancer, October 9-11 2013 182
Two distinct inwardly rectifying conductances are expressed in long term dibutyryl-cyclic-AMP treated rat cultured cortical astrocytes. 180
Cationic lipid/DNA complexes manufactured by microfluidics and bulk self-assembly exhibit different transfection behavior 180
Characterization of two voltage-dependent, inwardly rectifying currents in dibutyryl-cyclic AMP treated cortical astrocytes 179
Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A 176
Cascading glial reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. 176
Surface area of lipid membranes regulates the DNA-binding capacity of cationic liposomes. 175
Mechanistic Understanding of Gene Delivery Mediated by Highly Efficient Multicomponent Envelope-Type Nanoparticle Systems 175
Effects of a supplementation with tart cherry (Prunus cerasus L.) juice and its kernel extract on antioxidant status and muscle health 171
Effect of pH on the structure of lipoplexes 168
Glia-related pathomechanisms in Alzheimer' s disease: a therapeutic target? 167
Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. 167
Programmed packaging of multicomponent envelope-type nanoparticle system for gene delivery. 165
Efficient Delivery of DNA Using Lipid Nanoparticles 164
Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes 163
p185neu-Encoding DNA and therapeutical uses thereof 162
Self-assembled ternary complexes of neutral liposomes, DNA and bivalent metal cations. Promising vectors for gene transfer? 161
DNA codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici 161
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 160
DNA codificante p185neu e suoi usi terapeutici 158
Programmed packaging of multicomponent envelope-type nanoparticle system (MENS). 157
Stathmin is required for normal mouse mammary gland development and Δ16HER2-driven tumorigenesis 153
Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth 152
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favors early tumor growth in syngeneic mice. 151
Mesenchymal/stromal gene expression signature relates to Basal-like breast cancers, identify bone metastasis and predicts resistance to therapies. 149
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 149
Structural stability against disintegration by anionic lipids rationalizes the efficency of cationic liposom/DNA complexes 147
A Study of Bioactivities and Composition of a Cocktail of Supernatants Derived from Lactic Acid Bacteria for Potential Food Applications 143
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 143
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 142
Different expression of membrane conductances in cultured rat cortical astrocytes induced by intracellular cyclic-AMP elevation 130
Totale 22.082
Categoria #
all - tutte 93.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 0 0 0 0 0 0 259
2021/20221.362 90 314 37 60 95 84 52 96 128 117 154 135
2022/20231.653 172 43 88 214 171 239 10 140 300 103 124 49
2023/20241.224 158 75 82 42 55 138 46 40 139 41 26 382
2024/20253.941 145 69 292 153 133 184 520 1.019 318 300 225 583
2025/20265.575 407 339 432 810 616 441 968 442 240 411 369 100
Totale 24.592